Abstract | RATIONALE AND OBJECTIVES:
Gadobutrol is a new gadolinium-based hydrophilic and neutral macrocyclic contrast medium for magnetic resonance imaging. In this article, the authors report on the first application of gadobutrol in humans, up to a dose of 0.5 mmol/kg. METHODS:
Gadobutrol was investigated after single intravenous administration in two phase-1 studies testing low (0.5 mol/L) and high concentrations (1 mol/L) in healthy, male volunteers using a double-blind, randomized, placebo-controlled study with n = 55 for the low concentration (0.04, 0.1, 0.2, 0.3, and 0.4 mmol/kg body weight), followed by n = 36 for the high concentration (0.3, 0.4, and 0.5 mmol/kg body weight). Vital signs and laboratory parameters were measured for all dose groups investigated, whereas for the calculation of the pharmacokinetic parameters, the dose groups 0.04, 0.1, and 0.4 mmol/kg body weight were selected. RESULTS:
Gadobutrol was well tolerated up to doses of 0.5 mmol/kg, and no relevant changes in vital signs and laboratory parameters occurred. The terminal disposition half-life of gadobutrol in plasma was approximately 1.5 hours. Total clearance approximated renal clearance and approximated the value of 120 mL/min, indicating glomerular filtration as the main pathway of elimination. The steady-state volume of distribution indicated predominantly extracellular distribution of gadobutrol. No metabolites were detected. The renal excretion rate was linear over the large dose range tested, indicating dose-proportionate, first-order kinetics of gadobutrol. CONCLUSION:
|
Authors | T Staks, G Schuhmann-Giampieri, T Frenzel, H J Weinmann, L Lange, J Platzek |
Journal | Investigative radiology
(Invest Radiol)
Vol. 29
Issue 7
Pg. 709-15
(Jul 1994)
ISSN: 0020-9996 [Print] United States |
PMID | 7960618
(Publication Type: Clinical Trial, Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Contrast Media
- Organometallic Compounds
- Placebos
- gadobutrol
- Gadolinium
|
Topics |
- Adult
- Contrast Media
(administration & dosage, metabolism, pharmacokinetics, pharmacology)
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Tolerance
- Feces
(chemistry)
- Gadolinium
(administration & dosage, metabolism, pharmacokinetics, pharmacology)
- Half-Life
- Humans
- Injections, Intravenous
- Male
- Organometallic Compounds
(administration & dosage, metabolism, pharmacokinetics, pharmacology)
- Placebos
- Safety
|